| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 298.140 | 333.046 | 326.263 | 317.272 | 233.796 | 316.733 | 332.303 | 249.105 | 212.634 | 178.437 |
| Total Income - EUR | 302.221 | 334.277 | 327.224 | 318.701 | 350.341 | 316.993 | 332.362 | 249.416 | 213.488 | 178.938 |
| Total Expenses - EUR | 295.442 | 325.236 | 302.189 | 299.442 | 311.456 | 262.426 | 267.185 | 220.916 | 195.285 | 171.472 |
| Gross Profit/Loss - EUR | 6.779 | 9.041 | 25.036 | 19.259 | 38.885 | 54.567 | 65.176 | 28.500 | 18.202 | 7.465 |
| Net Profit/Loss - EUR | 5.821 | 6.893 | 15.458 | 16.072 | 35.379 | 51.777 | 62.409 | 26.465 | 16.228 | 6.012 |
| Employees | 6 | 5 | 5 | 5 | 4 | 3 | 2 | 3 | 2 | 2 |
Check the financial reports for the company - Parapharm Plus S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 126.479 | 118.111 | 112.413 | 109.003 | 45.429 | 41.468 | 34.839 | 29.672 | 25.790 | 26.549 |
| Current Assets | 371.744 | 302.944 | 262.489 | 301.302 | 325.016 | 365.372 | 327.733 | 337.796 | 283.576 | 251.449 |
| Inventories | 143.522 | 133.018 | 96.455 | 72.033 | 91.738 | 111.445 | 110.781 | 109.515 | 103.915 | 97.814 |
| Receivables | 226.540 | 168.840 | 164.406 | 202.583 | 232.003 | 243.153 | 180.337 | 153.936 | 169.755 | 142.747 |
| Cash | 1.682 | 1.086 | 1.628 | 26.687 | 1.275 | 10.774 | 36.616 | 74.345 | 9.906 | 10.889 |
| Shareholders Funds | 98.117 | 14.939 | 16.508 | 27.979 | 62.816 | 113.402 | 104.140 | 88.237 | 17.199 | 9.241 |
| Social Capital | 900 | 891 | 876 | 860 | 843 | 827 | 809 | 811 | 809 | 804 |
| Debts | 432.383 | 406.121 | 358.394 | 382.325 | 307.615 | 293.438 | 258.433 | 279.231 | 292.168 | 268.757 |
| Income in Advance | 0 | 0 | 0 | 0 | 13 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Parapharm Plus S.r.l.